Skip to main content

Compare Stocks

Date Range: 

 Cara TherapeuticsZymeworksEndo InternationalZealand Pharma A/SPMV Pharmaceuticals
SymbolNASDAQ:CARANYSE:ZYMENASDAQ:ENDPNASDAQ:ZEALNASDAQ:PMVP
Price Information
Current Price$13.20$28.59$5.61$29.00$32.09
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score1.81.61.51.21.4
Analysis Score3.53.43.03.52.4
Community Score3.12.82.62.52.9
Dividend Score0.00.00.00.00.0
Ownership Score1.71.71.70.01.7
Earnings & Valuation Score0.60.00.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$32.00$51.33$7.67$43.00$38.00
% Upside from Price Target142.42% upside79.55% upside36.66% upside48.28% upside18.42% upside
Trade Information
Market Cap$660.69 million$1.32 billion$1.31 billion$1.26 billion$1.44 billion
Beta1.70.751.411.19N/A
Average Volume1,051,990524,0683,819,25011,822163,194
Sales & Book Value
Annual Revenue$19.89 million$29.54 million$2.91 billion$6.20 millionN/A
Price / Sales33.2244.690.45203.23N/A
CashflowN/AN/A$4.07 per shareN/AN/A
Price / CashN/AN/A1.38N/AN/A
Book Value$4.66 per share$6.21 per share($3.82) per share$5.85 per shareN/A
Price / Book2.834.60-1.474.96N/A
Profitability
Net Income$-106,370,000.00$-145,440,000.00$-422,640,000.00$-85,670,000.00N/A
EPS($2.49)($3.83)$2.38($2.54)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/A2.44N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-360.35%-569.13%-5.30%-214.31%N/A
Return on Equity (ROE)-64.36%-44.06%-85.80%-38.34%N/A
Return on Assets (ROA)-53.22%-34.36%7.19%-30.40%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio8.00%6.48%2.17%6.76%N/A
Quick Ratio8.00%6.48%1.90%6.51%N/A
Ownership Information
Institutional Ownership Percentage67.01%75.11%79.98%4.32%69.72%
Insider Ownership Percentage5.70%4.20%1.50%N/AN/A
Miscellaneous
Employees803523,39732944
Shares Outstanding50.05 million46.17 million233.31 million43.45 million44.93 million
Next Earnings Date8/9/2021 (Estimated)8/4/2021 (Estimated)8/4/2021 (Estimated)8/12/2021 (Estimated)8/13/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
SourceHeadline
PMV Pharmaceuticals (NASDAQ:PMVP) Shares Up 10.2%PMV Pharmaceuticals (NASDAQ:PMVP) Shares Up 10.2%
americanbankingnews.com - May 14 at 2:38 PM
PMV Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate HighlightsPMV Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Highlights
finance.yahoo.com - May 14 at 1:00 PM
PMV Pharmaceuticals (NASDAQ:PMVP) Sees Unusually-High Trading VolumePMV Pharmaceuticals (NASDAQ:PMVP) Sees Unusually-High Trading Volume
americanbankingnews.com - May 13 at 11:54 AM
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Director Sells $63,742.29 in StockPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Director Sells $63,742.29 in Stock
americanbankingnews.com - May 12 at 9:36 PM
Relative Strength Alert For PMV PharmaceuticalsRelative Strength Alert For PMV Pharmaceuticals
nasdaq.com - May 12 at 1:40 PM
PMV Pharmaceuticals (NASDAQ:PMVP) Hits New 1-Year Low at $27.00PMV Pharmaceuticals (NASDAQ:PMVP) Hits New 1-Year Low at $27.00
americanbankingnews.com - May 12 at 10:58 AM
PMV Pharmaceuticals (NASDAQ:PMVP) Stock Price Down 13.9% on Insider SellingPMV Pharmaceuticals (NASDAQ:PMVP) Stock Price Down 13.9% on Insider Selling
americanbankingnews.com - May 11 at 11:30 AM
Leila Alland Sells 4,000 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) StockLeila Alland Sells 4,000 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Stock
americanbankingnews.com - May 10 at 6:20 PM
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) CFO Winston Kung Sells 4,500 SharesPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) CFO Winston Kung Sells 4,500 Shares
americanbankingnews.com - May 5 at 4:34 AM
Were Interested To See How PMV Pharmaceuticals (NASDAQ:PMVP) Uses Its Cash Hoard To GrowWe're Interested To See How PMV Pharmaceuticals (NASDAQ:PMVP) Uses Its Cash Hoard To Grow
nasdaq.com - May 2 at 2:24 PM
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 4.7%PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 4.7%
americanbankingnews.com - April 27 at 11:58 AM
PMV Pharmaceuticals (NASDAQ:PMVP) Sees Strong Trading VolumePMV Pharmaceuticals (NASDAQ:PMVP) Sees Strong Trading Volume
americanbankingnews.com - April 22 at 11:59 AM
PMV Pharmaceuticals (NASDAQ:PMVP) Shares Gap Up to $31.26PMV Pharmaceuticals (NASDAQ:PMVP) Shares Gap Up to $31.26
americanbankingnews.com - April 21 at 12:54 PM
Abeona Therapeutics Appoints Two Industry Leaders as New Independent Members to Its Board of DirectorsAbeona Therapeutics Appoints Two Industry Leaders as New Independent Members to Its Board of Directors
benzinga.com - April 19 at 7:35 AM
Pmv Pharmaceuticals Inc (PMVP)Pmv Pharmaceuticals Inc (PMVP)
investing.com - April 12 at 12:40 AM
PMV Pharma Presents Late-Breaking Preclinical...PMV Pharma Presents Late-Breaking Preclinical...
benzinga.com - April 10 at 6:16 PM
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the ...PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the ...
apnews.com - April 10 at 6:16 PM
PMV Pharmaceuticals Inc. [PMVP] is -46.33% lower this YTD. Is it still time to buy?PMV Pharmaceuticals Inc. [PMVP] is -46.33% lower this YTD. Is it still time to buy?
dbtnews.com - March 25 at 11:09 PM
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Down Almost -10.23% in 1 Month, But Long Term Looking GoodPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Down Almost -10.23% in 1 Month, But Long Term Looking Good
marketingsentinel.com - March 25 at 1:07 PM
PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American ...PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American ...
apnews.com - March 11 at 7:59 AM
PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate ...PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate ...
apnews.com - March 4 at 3:38 AM
PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights Nasdaq:PMVPPMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights Nasdaq:PMVP
compsmag.com - March 3 at 10:37 PM
PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate HighlightsPMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
finance.yahoo.com - March 3 at 5:35 PM
PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory BoardPMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board
finance.yahoo.com - February 16 at 9:14 AM
Were Not Worried About PMV Pharmaceuticals (NASDAQ:PMVP) Cash BurnWe're Not Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn
finance.yahoo.com - December 25 at 3:10 PM
DateCompanyBrokerageAction
5/5/2021Cara TherapeuticsNeedham & Company LLCLower Price Target
9/8/2020Cara TherapeuticsCanaccord GenuityReiterated Rating
5/19/2020Cara TherapeuticsCantor FitzgeraldBoost Price Target
4/21/2020Cara TherapeuticsHC WainwrightBoost Price Target
7/30/2019Cara TherapeuticsPiper Jaffray CompaniesBoost Price Target
5/29/2019Cara TherapeuticsLaidlawBoost Price Target
2/6/2019Cara TherapeuticsJefferies Financial GroupInitiated Coverage
1/15/2019Cara TherapeuticsBank of AmericaInitiated Coverage
5/6/2021ZymeworksRaymond JamesSet Price Target
3/30/2021ZymeworksCredit Suisse GroupInitiated Coverage
3/3/2021ZymeworksSVB LeerinkReiterated Rating
1/29/2021ZymeworksCitigroupUpgrade
1/28/2021ZymeworksWells Fargo & CompanyLower Price Target
1/28/2021ZymeworksBarclaysLower Price Target
9/29/2020ZymeworksJPMorgan Chase & Co.Initiated Coverage
4/7/2021Endo InternationalRoyal Bank of CanadaInitiated Coverage
3/9/2021Endo InternationalMorgan StanleyBoost Price Target
1/4/2021Endo InternationalPiper SandlerBoost Price Target
7/27/2020Endo InternationalThe Goldman Sachs GroupInitiated Coverage
7/8/2020Endo InternationalSunTrust BanksReiterated Rating
8/7/2019Endo InternationalMizuhoReiterated Rating
9/19/2019Zealand Pharma A/SGuggenheimInitiated Coverage
10/20/2020PMV PharmaceuticalsEvercore ISIInitiated Coverage
10/20/2020PMV PharmaceuticalsCowenInitiated Coverage
(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.